StockData
Citius Oncology, Inc. logo

Citius Oncology, Inc. (CTOR) stock

CTORNasdaqPharmaceutical PreparationsFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 2/30
$0.56+0.01 (+1.79%)

Close on Nov 18, 2026Market cap $51.83MP/E –Yield –

Citius Oncology free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

No free cash flow figures for Citius Oncology

Citius Oncology has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Citius Oncology figures

See a number that looks wrong?